BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9159072)

  • 1. Mammalian RNA-dependent deaminases and edited mRNAs.
    Maas S; Melcher T; Seeburg PH
    Curr Opin Cell Biol; 1997 Jun; 9(3):343-9. PubMed ID: 9159072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mammalian RNA editing enzyme.
    Melcher T; Maas S; Herb A; Sprengel R; Seeburg PH; Higuchi M
    Nature; 1996 Feb; 379(6564):460-4. PubMed ID: 8559253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of nuclear mRNA editing].
    Kostyrko A; Trzeciak WH
    Postepy Biochem; 1998; 44(2):94-101. PubMed ID: 9770232
    [No Abstract]   [Full Text] [Related]  

  • 4. Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase.
    Dabiri GA; Lai F; Drakas RA; Nishikura K
    EMBO J; 1996 Jan; 15(1):34-45. PubMed ID: 8598204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide to RNA editing.
    Smith HC; Gott JM; Hanson MR
    RNA; 1997 Oct; 3(10):1105-23. PubMed ID: 9326486
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.
    Maas S; Melcher T; Herb A; Seeburg PH; Keller W; Krause S; Higuchi M; O'Connell MA
    J Biol Chem; 1996 May; 271(21):12221-6. PubMed ID: 8647818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.
    Kim U; Wang Y; Sanford T; Zeng Y; Nishikura K
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11457-61. PubMed ID: 7972084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
    Davidson NO; Anant S; MacGinnitie AJ
    Curr Opin Lipidol; 1995 Apr; 6(2):70-4. PubMed ID: 7773570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase.
    Navaratnam N; Morrison JR; Bhattacharya S; Patel D; Funahashi T; Giannoni F; Teng BB; Davidson NO; Scott J
    J Biol Chem; 1993 Oct; 268(28):20709-12. PubMed ID: 8407891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.
    Wedekind JE; Dance GS; Sowden MP; Smith HC
    Trends Genet; 2003 Apr; 19(4):207-16. PubMed ID: 12683974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA editing by base deamination: more enzymes, more targets, new mysteries.
    Gerber AP; Keller W
    Trends Biochem Sci; 2001 Jun; 26(6):376-84. PubMed ID: 11406411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing.
    Palladino MJ; Keegan LP; O'Connell MA; Reenan RA
    RNA; 2000 Jul; 6(7):1004-18. PubMed ID: 10917596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
    Navaratnam N; Fujino T; Bayliss J; Jarmuz A; How A; Richardson N; Somasekaram A; Bhattacharya S; Carter C; Scott J
    J Mol Biol; 1998 Jan; 275(4):695-714. PubMed ID: 9466941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
    Anant S; Martin SA; Yu H; MacGinnitie AJ; Devaney E; Davidson NO
    Mol Biochem Parasitol; 1997 Sep; 88(1-2):105-14. PubMed ID: 9274872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B messenger RNA editing: an update.
    Chan L
    Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.